Kandil Emad, Saeed Ahmad, Buell Joseph
Division of Endocrine and Oncologic Surgery, Department of Surgery, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Gland Surg. 2015 Oct;4(5):442-6. doi: 10.3978/j.issn.2227-684X.2015.04.10.
Liver is the commonest site for metastasis in patients with neuroendocrine tumors (NETs); it occurs in 45-95% of patients. Available treatment options include surgical resection, liver transplantation, chemotherapy and biotherapy. Surgery is the gold standard for curative therapy. Typically, a multidisciplinary approach is a cornerstone for decision making while dealing with this aggressive disease. This review will focus on the performance and safety of open, laparoscopic, and liver transplant surgical approaches in NETs patients with liver metastases.
肝脏是神经内分泌肿瘤（NETs）患者最常见的转移部位；45%至95%的患者会出现肝转移。现有的治疗选择包括手术切除、肝移植、化疗和生物治疗。手术是根治性治疗的金标准。通常，多学科方法是应对这种侵袭性疾病时决策的基石。本综述将聚焦于开放性手术、腹腔镜手术和肝移植手术治疗NETs肝转移患者的疗效及安全性。
